Lisata TherapeuticsLSTA
13F holders, Q1 2024 (March 31)21holders
1famous investor
$3.12avg. 13F price*
At the end of Q1 2024, 21 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings. The largest holders were BML Capital Management, LLC ($888K), Vanguard Group Inc. ($567K) and Renaissance Technologies ($311K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lisata Therapeutics Inc.
- CUSIP
- 128058302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $36K |
| Exits | 2 | $39K |
Ownership 21 holders
| BML Capital Management, LLC | 0.59% | Add +5.5% | 284,669 | $888K |
| Vanguard Group Inc. | 0.00% | Add +2.7% | 181,692 | $567K |
| Renaissance Technologies | 0.00% | Add +2.4% | 99,522 | $311K |
| BlackRock Inc. | 0.00% | Reduce -0.4% | 56,013 | $175K |
| Geode Capital Management, LLC | 0.00% | Add +2.2% | 44,350 | $138K |
| State Street Corp. | 0.00% | No change | 14,348 | $45K |
| Dimensional Fund Advisors LP | 0.00% | New | 11,697 | $36K |
| Cook Wealth, LLC | 0.02% | No change | 12,175 | $36K |
| Susquehanna International Group, LLP | 0.00% | Reduce -68.2% | 10,719 | $33K |
| HighTower Advisors, LLC | 0.00% | No change | 10,044 | $31K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 9,658 | $30K |
| Morgan Stanley | 0.00% | No change | 2,550 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -17.1% | 853 | $3K |
| Founders Capital Management | 0.00% | No change | 333 | $1K |
| Wells Fargo & Company | 0.00% | Add +1.9% | 54 | $168 |
| JPMorgan Chase & Co. | 0.00% | Add +45.5% | 16 | $50 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $19 |
| Barclays PLC | 0.00% | No change | 4 | $12 |
| UBS Group AG | 0.00% | Reduce -99.6% | 1 | $3 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $3 |
| Royal Bank of Canada | 0.00% | No change | 52 | $0 |
"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.